Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ginsberg

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Epilepsy Research|August 26, 2022
"Virtual patch clamp analysis" for predicting the functional significance of pathogenic variants in sodium channelsN Bielopolski, E Heyman, H Bassan, et al.
Plos One|May 13, 2017
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, et al.
Pharmacoeconomics|January 31, 2002
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitisPhilippe Beutels, W John Edmunds, Fernando Antoñanzas, et al.
Critical Care Medicine|February 1, 1996
Cerebral resuscitation from cardiac arrest: pathophysiologic mechanismsP Vaagenes, M Ginsberg, U Ebmeyer, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2018
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection TrialSara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
Critical Care Medicine|February 1, 1996
Cerebral resuscitation from cardiac arrest: treatment potentialsS E Gisvold, F Sterz, N S Abramson, et al.
Communications Biology|October 10, 2020
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccinesVirginie Rozot, Elisa Nemes, Hennie Geldenhuys, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2019
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tubeElisa Nemes, Deborah Abrahams, Thomas J Scriba, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Epilepsy Research|August 26, 2022
"Virtual patch clamp analysis" for predicting the functional significance of pathogenic variants in sodium channelsN Bielopolski, E Heyman, H Bassan, et al.
Plos One|May 13, 2017
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, et al.
Pharmacoeconomics|January 31, 2002
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitisPhilippe Beutels, W John Edmunds, Fernando Antoñanzas, et al.
Critical Care Medicine|February 1, 1996
Cerebral resuscitation from cardiac arrest: pathophysiologic mechanismsP Vaagenes, M Ginsberg, U Ebmeyer, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2018
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection TrialSara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
Critical Care Medicine|February 1, 1996
Cerebral resuscitation from cardiac arrest: treatment potentialsS E Gisvold, F Sterz, N S Abramson, et al.
Communications Biology|October 10, 2020
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccinesVirginie Rozot, Elisa Nemes, Hennie Geldenhuys, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2019
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tubeElisa Nemes, Deborah Abrahams, Thomas J Scriba, et al.
Pageof 19